Delphi Diagnostics Announces New Publication in the European Journal of Cancer

Peer-reviewed manuscript demonstrates the Endocrine Activity IndexTM Recurrence Risk (EAIRR) enhances risk stratification beyond Recurrence Score® and is predictive of endocrine therapy benefit HOUSTON, May 6, 2026 /PRNewswire/ -- Delphi Diagnostics today announced the publication of new...